CytoDyn Inc. Annual report pursuant to Section 13 and 15(d)

Annual report pursuant to Section 13 and 15(d)

Convertible Instruments and Accrued Interest - Components (Details)

Convertible Instruments and Accrued Interest - Components (Details) - USD ($) $ in Thousands	3 Months Ended					6 Months Ended		9 Months Ended		12 Months Ended
	Feb. 28, 2022	Nov. 30, 2021	Aug. 31, 2021	Feb. 28, 2021	Nov. 30, 2020	Nov. 30, 2021	Nov. 30, 2020	Feb. 28, 2022	Feb. 28, 2021	May 31, 2022	May 31, 2021
Debt Instrument [Line Items]
Outstanding balance, beginning			$ 64,754			$ 64,754		$ 64,754		$ 64,754
Amortization of issuance discount and costs										3,045
Interest expense										5,417
Fair market value of shares exchanged for repayment										(42,073)
Loss on induced conversion	$ 12,066	$ 6,785	18,530		$ 6,724	25,315	$ 6,724	37,381	$ 6,724	37,381	$ 39,131
Difference between market value of common shares and reduction of principle										(11,072)
Outstanding balance, ending										42,215	64,754
Previously Reported
Debt Instrument [Line Items]
Loss on induced conversion	3,109	3,312	4,651	$ 7,625	4,169	7,963	4,169	11,072	11,794		19,896
Adjustments
Debt Instrument [Line Items]
Loss on induced conversion	$ 8,957	$ 3,473	13,879	$ (7,625)	$ 2,555	17,352	$ 2,555	26,309	$ (5,070)		19,235
Long-term Convertible Note-March 2020 Note \| Adjustments
Debt Instrument [Line Items]
Loss on induced conversion											3,100
Long-term Convertible Note-July 2020 Note \| Adjustments
Debt Instrument [Line Items]
Loss on induced conversion											14,100
Long-term Convertible Note - November 2020 Note
Debt Instrument [Line Items]
Outstanding balance, beginning			13,554			13,554		13,554		13,554
Amortization of issuance discount and costs										98
Interest expense										192
Fair market value of shares exchanged for repayment										(18,495)
Difference between market value of common shares and reduction of principle										(4,651)
Outstanding balance, ending											13,554
Long-term Convertible Note - November 2020 Note \| Adjustments
Debt Instrument [Line Items]
Loss on induced conversion										13,900	2,000
Long-term Convertible Note - April 2, 2021 Note
Debt Instrument [Line Items]
Outstanding balance, beginning			25,715			25,715		25,715		25,715
Amortization of issuance discount and costs										1,197
Interest expense										2,152
Fair market value of shares exchanged for repayment										(23,578)
Difference between market value of common shares and reduction of principle										(6,421)
Outstanding balance, ending										11,907	25,715
Long-term Convertible Note - April 2, 2021 Note \| Adjustments
Debt Instrument [Line Items]
Loss on induced conversion										12,400
Long-term Convertible Note - April 23, 2021 Note
Debt Instrument [Line Items]
Outstanding balance, beginning			$ 25,485			$ 25,485		$ 25,485		25,485
Amortization of issuance discount and costs										1,750
Interest expense										3,073
Outstanding balance, ending										$ 30,308	$ 25,485